Regenxbio (RGNX) Cost of Revenue (2014 - 2024)
Regenxbio's Cost of Revenue was $6.32 million in Q4 2024, down 43.8% from $11.24 million a year earlier and down 49.0% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Cost of Revenue (2014 - 2024) Analysis & Trends
For FY2024, Cost of Revenue at Regenxbio came in at $33.57 million, down 9.8% from FY2023.
- Cost of Revenue shows a five-year compound annual growth rate of 32.4% (FY2019 to FY2024).
- In earlier years, Cost of Revenue was $37.21 million in FY2023 (-31.8%), $54.55 million in FY2022 (+5.2%), $51.83 million in FY2021 (+45.1%) and $35.71 million in FY2020 (+333.4%).
- Quarterly Cost of Revenue has moved between $3.41 million (Q1 2020) and $23.06 million (Q4 2021) over five years.
- Compared with a year earlier, Cost of Revenue was higher in two of the last eight quarters, with an average decline of 18.3%.
- The best year-over-year quarter for Cost of Revenue over five years was Q3 2020 (growth of 596.2%); the worst was Q1 2023 (a decline of 73.8%).
- Per Business Quant data, RGNX's Cost of Revenue in the three quarters before Q4 2024 was $12.39 million (Q3 2024), $10.58 million (Q2 2024) and $4.28 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Regenxbio | 402.44 Mn | -530.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 6.32 Mn |
| Sep 30, 2024 | 12.39 Mn |
| Jun 30, 2024 | 10.58 Mn |
| Mar 31, 2024 | 4.28 Mn |
| Dec 31, 2023 | 11.24 Mn |
| Sep 30, 2023 | 12.39 Mn |
| Jun 30, 2023 | 9.48 Mn |
| Mar 31, 2023 | 4.11 Mn |
| Dec 31, 2022 | 12.78 Mn |
| Sep 30, 2022 | 13.09 Mn |
| Jun 30, 2022 | 12.95 Mn |
| Mar 31, 2022 | 15.72 Mn |
| Dec 31, 2021 | 23.06 Mn |
| Sep 30, 2021 | 14.11 Mn |
| Jun 30, 2021 | 9.82 Mn |
| Mar 31, 2021 | 4.85 Mn |
| Dec 31, 2020 | 10.26 Mn |
| Sep 30, 2020 | 17.36 Mn |
| Jun 30, 2020 | 4.68 Mn |
| Mar 31, 2020 | 3.41 Mn |
API Access
Regenxbio Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();